186
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Patient risk factors for developing a drug-related problem in a cardiology ward

, , , , , , , & show all
Pages 9-15 | Published online: 17 Dec 2014

References

  • WongCYChaudhrySIDesaiMMKrumholzHMTrends in comorbidity, disability, and polypharmacy in heart failureAm J Med2011124213614321295193
  • MasoudiFAKrumholzHMPolypharmacy and comorbidity in heart failureBMJ200332751351412958085
  • LedwidgeMTraversBRyderMRyanEMcDonaldKSpecialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactionsEur J Heart Fail2004623524314984732
  • MasoudiFABaillieCAWangYThe complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998–2001Arch Intern Med20051652069207616216996
  • Pharmaceutical Care Network Europe [homepage on the Internet]The PCNE Classification for drug-related problems V 6.2 [updated January 14, 2010]. Available from: http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdfAccessed September 1, 2014
  • NiquilleABugnonORelationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patientsPharm World Sci20103251251920526741
  • GastelurrutiaPBenrimojSIEspejoJTuneuLManguesMABayes-GenisANegative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinicJ Card Fail201117321722321362530
  • ASHP Section of Pharmacy Informatics and DevelopmentASHP guidelines on pharmacy planning for implementation of computerized provider-order-entry systems in hospitals and health systemsAm J Health Syst Pharm201168e9e3121378288
  • BedouchPAllenetBGrassADrug-related problems in medical wards with a computerized physician order entry systemJ Clin Pharm Ther20093418719519250139
  • RotenIMartySBeneyJElectronic screening of medical records to detect inpatients at risk of drug-related problemsPharm World Sci20103210310720012362
  • OnderGPetrovicMTangiisuranBDevelopment and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk scoreArch Intern Med2010170131142114820625022
  • UrbinaOFerrándezOGrauSDesign of a score to identify hospitalized patients at risk of drug-related problemPharmacoepidemiol Drug Saf201423992393224817497
  • Estudis d’Economia de la salut (volum III). Planificació i AvaluacióDepartament de Salut. Generalitat de Catalunya2010 Available from: http://www.saveva.com/domamPlus/pub/depsalut/html/ca/dir505/estecosalutiii.pdfAccessed February 14, 2014
  • BlixHSViktilKKReikvamAThe majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitalsEur J Clin Pharmacol20046065165815568140
  • BaumhakelMMullerUBohmMInfluence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional studyEur J Heart Fail20091129930319158153
  • ReppKLHayesCWoodsTMAllenKBKennedyKBorkonMADrug-related problems and hospital admissions in cardiac transplant recipientsAnn Pharmacother2012461299130723032656
  • AhmadAHugtenburgJWelschenLMDekkerJMNijpelsGEffect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trialBMC Public Health20101013320230611
  • BatesDWMillerEBCullenDJPatient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study GroupArch Intern Med19991592553256010573045
  • PetersonEDAlbertNMAminAPattersonJHFonarowGCImplementing critical pathways and a multidisciplinary team approach to cardiovascular disease managementAm J Cardiol20081025A47G56G18572034
  • AltowaijriAPhillipsCJFitzsimmonsDA systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular diseaseJ Manag Care Pharm201319540841623697478
  • Milfred-LaforestSKChowSLDidomenicoRJClinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkPharmacotherapy201333552954823649813
  • BerraKFletcherBHaymanLLMillerNHGlobal cardiovascular disease prevention: a call to action for nursing executive summaryJ Cardiovasc Nurs201328650551322955185
  • McAlisterFAStewartSFerruaSMcMurrayJJMultidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trialsJ Am Coll Cardiol200444481081915312864
  • HollandRBattersbyJHarveyILenaghanESmithJHayLSystematic review of multidisciplinary interventions in heart failureHeart20059189990615958358
  • BatesDWSpellNCullenDJThe costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study GroupJAMA199727743073119002493
  • ClassenDCPestotnikSLEvansRSLloydJFBurkeJPAdverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortalityJAMA19972743013069002492
  • SchneiderPJGiftMGLeeYPRothermichEASillBECost of medication-related problems at a university hospitalAm J Health Syst Pharm19955221241524188564605
  • OnderGvan der CammenTPetrovicMSomersARajkumarCStrategies to reduce the risk of iatrogenic illness in complex older adultsAge Ageing20134228429123537588